EBR Systems 3Q 2026: Revenue $2.49M, EPS ($0.21) — 10-Q Summary
Less than 1 min read
EBR Systems’ net sales rose year over year as WiSE CRT System implants expanded to 24 U.S. hospitals from four. The net loss widened, driven mainly by higher selling, general and administrative expenses and research and development costs, alongside a modest increase in other expense.
Financial Highlights
| Metric | Current quarter | Prior year quarter | YoY change |
| Revenue¹ | $2.49M | $512K | 385.7% |
| Net income² | ($16.64M) | ($12.19M) | (36.5%) |
| Diluted EPS³ | ($0.21) | ($0.27) | 22.2% |
¹ Reported as “Net sales”. ² Reported as “Net loss”. ³ Reported as “Basic and diluted”.
Business Highlights
- Commercial implants: The company completed 40 implants at 24 U.S. hospitals in the quarter.
- Gross margin: Gross margin was 10.0%, down from 43.8%; excluding previously expensed inventory, it improved to (8.9%) from (25.2%).
- Research and development: Spending rose 7.3%, reflecting higher post-approval study and Santa Clara facility costs, partly offset by lower personnel expenses.
- Selling and administration: Expenses increased 67.2%, primarily from workforce expansion and increased sales and ...